HER2 Overexpression Is a Major Risk Factor for Recurrence in pT1a-b, N0 Breast Cancer: A French Regional Population-Based Study of 671 Patients

被引：0
|
作者：
Bibeau, F.
Boissiere-Michot, F.
Denouel, A.
Szablewski, V.
Perrocchia, H.
Pignodel, C.
de Vullerin, A. Gudin
Leaha, C.
Chateau, M-C
Barneon, G.
Vic, P.
Garnier, A.
Granier, M.
Roger, P.
机构：
[1] CRLCC Val dAurelle, Montpellier, Herault, France
[2] Hop Gui De Chauliac, Montpellier, Herault, France
[3] Grp Hosp Univ, Nimes, Gard, France
[4] Ctr Pathol, Montpellier, Herault, France
[5] CACP Les Tonnelles, Montpellier, Herault, France
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
98
引用
收藏
页码：26A / 26A
页数：1
相关论文
共 50 条
  • [31] THE PROGNOSIS FACTORS IN T1N0M0 BREAST CANCER PATIENTS: A POPULATION-BASED STUDY FROM CHINA
    Liu, Y.
    Chen, S.
    Shao, Z.
    [J]. BREAST, 2013, 22 : S58 - S59
  • [32] Prognostic role of HER2 expression in patients with ER-positive/HER2-negative breast cancer: Results from a population-based cancer registry study
    Musolino, A.
    Serra, O.
    Pellegrino, B.
    Tommasi, C.
    Zanoni, D.
    Faccini, F.
    Michiara, M.
    Sgargi, P.
    Carrozzi, G.
    Ferretti, S.
    Grossi, V.
    Ravaioli, A.
    Zamagni, F.
    Falcini, F.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S298 - S299
  • [33] Prognostic Impact of Interval Breast Cancer Detection in Women with pT1aN0M0 Breast Cancer with HER2-positive Status: Results from a Multicenter Population-based Cancer Registry Study
    Boggiani, D.
    Sikokis, A.
    Rimanti, A.
    Pellegrino, B.
    Silini, E. M.
    Campanini, N.
    Barbieri, E.
    Cortesi, L.
    Panebianco, M.
    Porzio, R.
    Frassoldati, A.
    Sgargi, P.
    Falcini, F.
    Michiara, M.
    Musolino, A.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [34] Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study
    Musolino, A.
    Sikokis, A.
    Boggiani, D.
    Rimanti, A.
    Pellegrino, B.
    Silini, E. M.
    Campanini, N.
    Barbieri, E.
    Cortesi, L.
    Panebianco, M.
    Porzio, R.
    Frassoldati, A.
    Sgargi, P.
    Falcini, F.
    Michiara, M.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [35] HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab (vol 132, pg 61, 2008)
    O'Malley, F. P.
    Thomson, T.
    Julian, J.
    Have, C.
    Cosby, R.
    Gelmon, K.
    Andrulis, I
    Whelan, T.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2008, 132 (05) : 730 - 730
  • [36] Survival in patients with HR+/HER2− metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study
    Julien Simon
    Marie Chaix
    Oumar Billa
    Ariane Mamguem Kamga
    Patrick Roignot
    Sylvain Ladoire
    Charles Coutant
    Patrick Arveux
    Catherine Quantin
    Tienhan Sandrine Dabakuyo-Yonli
    [J]. British Journal of Cancer, 2020, 123 : 1071 - 1077
  • [37] A nomogram and risk stratification system for predicting survival in T1-2N0-1 breast cancer patients with liver metastasis in females: a population-based study
    Wang, Kaiyue
    Shen, Lu
    Chen, Yiding
    Tang, Zhe
    [J]. BIOMEDICAL ENGINEERING ONLINE, 2024, 23 (01)
  • [38] Prognostic Role of HER2 Expression in Patients with ER- positive/HER2-negative Breast Cancer. Results from a Population-Based Cancer Registry Study
    Musolino, Antonino
    Serra, Olga
    Pellegrino, Benedetta
    Tommasi, Chiara
    Zanoni, Daniele
    Faccini, Fabio
    Michiara, Maria
    Sgargi, Paolo
    Carrozzi, Giuliano
    Ferretti, Stefano
    Grossi, Veruska
    Ravaioli, Alessandra
    Zamagni, Federica
    Falcini, Fabio
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [39] Prognostic role of HER2 expression in patients with ER-positive/HER2-negative breast cancer: Results from a population-based cancer registry study.
    Musolino, Antonino
    Serra, Olga
    Pellegrino, Benedetta
    Tommasi, Chiara
    Zanoni, Daniele
    Cortesi, Laura
    Canino, Fabio
    Piacentini, Federico
    Sgargi, Paolo
    Michiara, Maria
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Dual HER2 blockade in the first-line treatment of metastatic breast cancer - A retrospective population-based observational study in Danish patients
    Christensen, Thomas
    Berg, Tobias
    Nielsen, Lise Birk
    Andersson, Michael
    Jensen, Maj-Britt
    Knoop, Ann
    [J]. BREAST, 2020, 51 : 34 - 39
12345